Table 3.
Regression analysis for change in IGF-1 standard deviation score (SDS) and the change in neurogenic and endothelial vasomotion domains and adjusted for change in waist circumference and/or insulin resistance.
| Neurogenic domain | Endothelial domain | |||||
|---|---|---|---|---|---|---|
| B | 95% CI | P value | B | 95% CI | P value | |
| Model 1 | ||||||
| IGF-1 SDS | 0.032 | (−0.014–0.078) | 0.16 | 0.085 | (0.004–0.166) | 0.04 |
| Model 2 | ||||||
| IGF-1 SDS | 0.015 | (−0.033–0.064) | 0.52 | 0.073 | (−0.017–0.162) | 0.11 |
| Waist circumference | -0.013 | (−0.029–0.002) | 0.09 | −0.009 | (−0.037–0.019) | 0.50 |
| Model 3 | ||||||
| IGF-1 SDS | 0.019 | (−0.032–0.071) | 0.45 | 0.078 | (−0.014–0.171) | 0.10 |
| Insulin resistance | 0.112 | (−0.087–0.311) | 0.26 | 0.058 | (−0.299–0.416) | 0.74 |
| Model 4 | ||||||
| IGF-1 SDS | 0.001 | (−0.053–0.054) | 0.97 | 0.065 | (−0.036–0.166) | 0.20 |
| Waist circumference | −0.014 | (−0.029–0.002) | 0.08 | −0.010 | (−0.038–0.019) | 0.50 |
| Insulin resistance | 0.119 | (−0.073–0.310) | 0.21 | 0.063 | (−0.299–0.425) | 0.72 |